Jeannot
Geneva, Switzerland
NCT Number: NCT03888599
A better understanding of the target audiences about HPV infection and HPV vaccination would surely allow for a better spread of this vaccination in Switzerland. In order to know if the target audiences are properly informed, we have decided to carry out a study evaluating their level of knowledge on a particular audience that are the men and women undergraduate nurse.
Looking for future studies?
Notify Me18 year–36 year
All sexes
Observational
Geneva, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
.Don't understand french language
, all enrolled undergraduate student received directly on your email the online questionnaire based on the "Fluid Survey tool", which was an on line survey tool (https://fluidsurveys.com/)
Time frame: 3 months
Percentage of right answer of the questionnaire
University Hospital, Geneva
Other
Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination Among Undergraduate Health Students From Switzerland
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03749707
Cervical Cancer, Female Urogenital Diseases
Aarhus, Denmark
View Trial DetailsNCT05783167
Blood-Borne Infections, Cervical Cancer
Bissau, Guinea-Bissau
View Trial DetailsNCT04679675
Cervical Cancer, Cervical Dysplasia
Seattle, Washington, United States
View Trial DetailsNCT05996796
Cervical Cancer, Cervical Intraepithelial Neoplasia
Edegem, Antwerp, Belgium
View Trial Details